Rate My Professor John Brannan

Brannan's research focuses on obstructive lung diseases, particularly asthma, airway hyperresponsiveness, exercise-induced bronchoconstriction, and chronic cough. He played a pivotal role in developing dry powder mannitol as a bronchial provocation test (Aridol or Osmohale), now registered in 26 countries worldwide. His contributions include over 128 publications, with 4,586 citations, key works such as 'The safety and efficacy of inhaled dry powder mannitol as a bronchial provocation test for airway hyperresponsiveness' (2006), 'Methods for "Indirect" Challenge Tests Including Exercise, Eucapnic Voluntary Hyperpnea and Hypertonic Aerosols' (2006), 'Daily Inhaled Corticosteroids Treatment Abolishes Airway Hyperresponsiveness to Mannitol in Mild Asthma' (2022), and 'The Olympics have arrived: The challenge of exercise-induced bronchoconstriction in athletes' (2024). He is author of the forthcoming book 'Airway hyperresponsiveness' (2025). Awards include the Asthma Foundation Summer Scholarship (1994), multiple travel scholarships, National Asthma Campaign Poster Prize (2009), Tracy Robinson Award for Teaching Excellence (2014), and Best Oral Presentation at the Australian & New Zealand Society of Respiratory Science Meeting (2018). Brannan has delivered presentations at international conferences and contributed to guidelines on chronic cough management.